Publications
Total number of publications: 285
2026
-
Casein kinase 1δ/ε inhibition suppresses CLL proliferation through cell-intrinsic and microenvironmental mechanisms
HemaSphere, year: 2026, volume: 10, edition: 3, DOI
-
Central nervous system involvement in CLL: an international retrospective study by ERIC, the European Research Initiative on CLL
Blood advances, year: 2026, volume: 10, edition: 2, DOI
-
Differential Expression of P-Element-Induced Wimpy Testis (PIWI)-Interacting RNAs in Glioblastoma Stem Cells Affects Their Biological Features: Implications for Tumor Progression and Patient Survival
Laboratory Investigation, year: 2026, volume: 106, edition: 3, DOI
-
Identification and functional assessment of a KCNH2 compound heterozygosity in a patient with presumed idiopathic ventricular fibrillation ascertains the diagnosis of long QT syndrome type 2
EP Europace, year: 2026, volume: 28, edition: 2, DOI
-
Improvement of severe hypertriglyceridemia in atypical subtype 4 partial lipodystrophy with volanesorsen
Journal of Clinical Lipidology, year: 2026, volume: 20, edition: 2, DOI
2025
-
Advanced NGS analysis of cell-free tumor DNA supports clonal relation to primary high-grade B-cell lymphoma lesion and CNS relapse despite MRI negativity
Diagnostic Pathology, year: 2025, volume: 20, edition: 1, DOI
-
Algorithm for the diagnosis of malignant hyperthermia
Anesteziologie a intenzivní medicína, year: 2025, volume: 36, edition: 2
-
Anti-Cancer Potential of a new Derivative of Caffeic Acid Phenethyl Ester targeting the Centrosome
Redox Biology, year: 2025, volume: 81, edition: April 2025, DOI
-
ATM aberrations in chronic lymphocytic leukemia: del(11q) rather than ATM mutations is an adverse-prognostic biomarker
Leukemia, year: 2025, volume: 39, edition: 7, DOI
-
Blinatumomab in induction therapy improves molecular response in untreated adults with Ph- B-cell precursor acute lymphoblastic leukemia
Haematologica, year: 2025, volume: 110, edition: 7, DOI